NSC 30272, with the CAS number 87234-28-4, is a chemical compound that has been studied primarily for its potential applications in medicinal chemistry, particularly in the context of cancer research. It is characterized by its unique molecular structure, which includes specific functional groups that contribute to its biological activity. The compound has shown promise in preclinical studies, exhibiting properties that may inhibit tumor growth or enhance the efficacy of other therapeutic agents. Its solubility, stability, and interaction with biological targets are key factors that influence its potential as a drug candidate. Additionally, NSC 30272 may undergo various metabolic processes in biological systems, which can affect its pharmacokinetics and overall effectiveness. As with many compounds in drug development, further research is necessary to fully understand its mechanisms of action, optimal dosing, and potential side effects. Overall, NSC 30272 represents a noteworthy example of the ongoing exploration of novel compounds in the field of cancer therapeutics.

NSC30272

87234-28-4: NSC 30272, with the CAS number 87234-28-4, is a chemical compound that has been studied primarily for its potential applications in medicinal chemistry, particularly in the context of cancer research. It is characterized by its unique molecular structure, which includes specific functional groups that contribute to its biological activity. The compound has shown promise in preclinical studies, exhibiting properties that may inhibit tumor growth or enhance the efficacy of other therapeutic agents. Its solubility, stability, and interaction with biological targets are key factors that influence its potential as a drug candidate. Additionally, NSC 30272 may undergo various metabolic processes in biological systems, which can affect its pharmacokinetics and overall effectiveness. As with many compounds in drug development, further research is necessary to fully understand its mechanisms of action, optimal dosing, and potential side effects. Overall, NSC 30272 represents a noteworthy example of the ongoing exploration of novel compounds in the field of cancer therapeutics.

CAS 87234-28-4

NSC30272

1,3-dichloro-2-phenylpropan-2-ol

Ref: 54-OR1036847